Cargando…

Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection

BACKGROUND: Targeted genomic editing using the CRISPR/Cas9 methodology has opened exciting new avenues in probing gene function in virtually any model system, including cultured mammalian cells. Depending on the desired mutation, several experimental options exist in the isolation of clonal lines, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Estep, Jason A., Sternburg, Erin L., Sanchez, Gissell A., Karginov, Fedor V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818936/
https://www.ncbi.nlm.nih.gov/pubmed/27038923
http://dx.doi.org/10.1186/s12867-016-0061-0
_version_ 1782425118675304448
author Estep, Jason A.
Sternburg, Erin L.
Sanchez, Gissell A.
Karginov, Fedor V.
author_facet Estep, Jason A.
Sternburg, Erin L.
Sanchez, Gissell A.
Karginov, Fedor V.
author_sort Estep, Jason A.
collection PubMed
description BACKGROUND: Targeted genomic editing using the CRISPR/Cas9 methodology has opened exciting new avenues in probing gene function in virtually any model system, including cultured mammalian cells. Depending on the desired mutation, several experimental options exist in the isolation of clonal lines, such as selection with introduced markers, or screening by PCR amplification of genomic DNA. However, streamlined approaches to establishing deletion and tagging mutants with minimal genomic perturbation are of interest in applying this methodology. RESULTS: We developed a procedure for rapid screening of clonal cell lines for the deletion of a protein of interest following CRISPR/Cas9 targeting in the absence of selective pressure based on dot immunoblots. To assess the technique, we probed clonal isolates of 293-TREx cells that were targeted with three separate sgRNAs against the HuR gene. Validation of knockout candidates by western blot indicated that the normalized protein abundances indicated by the dot blot serve as accurate predictors of deletion. In total, 32 independent biallelic deletion lines out of 248 screened clones were isolated, and recovery of null mutants ranged from 6 to 36 % for the individual sgRNAs. Genomic sequencing verified small deletions at the targeted locus. CONCLUSIONS: Clonal screening for CRISPR/Cas9-mediated editing events using dot immunoblot is a straightforward and efficient approach that facilitates rapid generation of genomic mutants to study gene function.
format Online
Article
Text
id pubmed-4818936
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48189362016-04-04 Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection Estep, Jason A. Sternburg, Erin L. Sanchez, Gissell A. Karginov, Fedor V. BMC Mol Biol Methodology Article BACKGROUND: Targeted genomic editing using the CRISPR/Cas9 methodology has opened exciting new avenues in probing gene function in virtually any model system, including cultured mammalian cells. Depending on the desired mutation, several experimental options exist in the isolation of clonal lines, such as selection with introduced markers, or screening by PCR amplification of genomic DNA. However, streamlined approaches to establishing deletion and tagging mutants with minimal genomic perturbation are of interest in applying this methodology. RESULTS: We developed a procedure for rapid screening of clonal cell lines for the deletion of a protein of interest following CRISPR/Cas9 targeting in the absence of selective pressure based on dot immunoblots. To assess the technique, we probed clonal isolates of 293-TREx cells that were targeted with three separate sgRNAs against the HuR gene. Validation of knockout candidates by western blot indicated that the normalized protein abundances indicated by the dot blot serve as accurate predictors of deletion. In total, 32 independent biallelic deletion lines out of 248 screened clones were isolated, and recovery of null mutants ranged from 6 to 36 % for the individual sgRNAs. Genomic sequencing verified small deletions at the targeted locus. CONCLUSIONS: Clonal screening for CRISPR/Cas9-mediated editing events using dot immunoblot is a straightforward and efficient approach that facilitates rapid generation of genomic mutants to study gene function. BioMed Central 2016-04-02 /pmc/articles/PMC4818936/ /pubmed/27038923 http://dx.doi.org/10.1186/s12867-016-0061-0 Text en © Estep et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Estep, Jason A.
Sternburg, Erin L.
Sanchez, Gissell A.
Karginov, Fedor V.
Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection
title Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection
title_full Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection
title_fullStr Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection
title_full_unstemmed Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection
title_short Immunoblot screening of CRISPR/Cas9-mediated gene knockouts without selection
title_sort immunoblot screening of crispr/cas9-mediated gene knockouts without selection
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818936/
https://www.ncbi.nlm.nih.gov/pubmed/27038923
http://dx.doi.org/10.1186/s12867-016-0061-0
work_keys_str_mv AT estepjasona immunoblotscreeningofcrisprcas9mediatedgeneknockoutswithoutselection
AT sternburgerinl immunoblotscreeningofcrisprcas9mediatedgeneknockoutswithoutselection
AT sanchezgissella immunoblotscreeningofcrisprcas9mediatedgeneknockoutswithoutselection
AT karginovfedorv immunoblotscreeningofcrisprcas9mediatedgeneknockoutswithoutselection